Omata M - Search Results

1

Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation.

Omata M, Tateishi R, Yoshida H, Shiina S. Omata M, et al. Gastroenterology. 2004 Nov;127(5 Suppl 1):S159-66. doi: 10.1053/j.gastro.2004.09.030. Gastroenterology. 2004. PMID: 15508080

2

Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma.

Akanuma M, Yoshida H, Okamoto M, Ogura K, Maeda S, Hata Y, Sato S, Shiina S, Kawabe T, Shiratori Y, Omata M. Akanuma M, et al. Among authors: omata m. Hepatogastroenterology. 2002 Jul-Aug;49(46):1039-44. Hepatogastroenterology. 2002. PMID: 12143197

3

Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy.

Teratani T, Ishikawa T, Shiratori Y, Shiina S, Yoshida H, Imamura M, Obi S, Sato S, Hamamura K, Omata M. Teratani T, et al. Among authors: omata m. Cancer. 2002 Aug 15;95(4):816-23. doi: 10.1002/cncr.10735. Cancer. 2002. PMID: 12209726 Free article. Clinical Trial.

4

Progression from chronic hepatitis to hepatocellular carcinoma: natural course and treatments.

Omata M, Yoshida H, Shiratori Y, Shiina S. Omata M, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S434-6. doi: 10.1046/j.1440-1746.17.s3.41.x. J Gastroenterol Hepatol. 2002. PMID: 12472977 Review. No abstract available.

5

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus.

Shiratori Y, Shiina S, Teratani T, Imamura M, Obi S, Sato S, Koike Y, Yoshida H, Omata M. Shiratori Y, et al. Among authors: omata m. Ann Intern Med. 2003 Feb 18;138(4):299-306. doi: 10.7326/0003-4819-138-4-200302180-00008. Ann Intern Med. 2003. PMID: 12585827 Clinical Trial.

6

Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.

Koike Y, Nakagawa K, Shiratori Y, Shiina S, Imamura M, Sato S, Obi S, Teratani T, Hamamura K, Yoshida H, Omata M. Koike Y, et al. Among authors: omata m. Hepatogastroenterology. 2003 Nov-Dec;50(54):2035-9. Hepatogastroenterology. 2003. PMID: 14696460

7

Prevention and treatment of hepatocellular carcinoma.

Omata M, Yoshida H. Omata M, et al. Liver Transpl. 2004 Feb;10(2 Suppl 1):S111-4. doi: 10.1002/lt.20046. Liver Transpl. 2004. PMID: 14762850 Free article. Review.

8

Re-appearance of power Doppler signals in the tumor nodules of hepatocellular carcinoma after transarterial embolization reflects residual viable tumor cells: histological confirmation.

Sato S, Shiratori Y, Imamura M, Obi S, Shiina S, Akahane M, Ohtomo K, Omata M. Sato S, et al. Among authors: omata m. Hepatogastroenterology. 2004 Jan-Feb;51(55):56-61. Hepatogastroenterology. 2004. PMID: 15011831

9

Neither hepatitis C virus genotype nor virus load affects survival of patients with hepatocellular carcinoma.

Akamatsu M, Yoshida H, Shiina S, Teratani T, Tateishi R, Obi S, Sato S, Koike Y, Fujishima T, Ishikawa T, Shiratori Y, Omata M. Akamatsu M, et al. Among authors: omata m. Eur J Gastroenterol Hepatol. 2004 May;16(5):459-66. doi: 10.1097/00042737-200405000-00004. Eur J Gastroenterol Hepatol. 2004. PMID: 15097037

10

[Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ].

Yoshida H, Tateishi R, Omata M. Yoshida H, et al. Among authors: omata m. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):511-4. Nihon Rinsho. 2004. PMID: 15359852 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,294 results

Search Page

Filters